12/28/2023 0 Comments Diptic diffuse idiopathic![]() Higher prevalence of neuroticism and psychoticism was found in severe bruxism group. Subjects in severe bruxism group presented more TMD-related signs and symptoms than those in negligible bruxism group. A total of 23Â♳4% subjects in negligible bruxism group and 48Â♶5% in severe bruxism group participated in the war. The proportion of military personnel presenting with bruxism is double the proportion of administrative employees with bruxism. No differences were found in gender distribution between the two groups. Subjects with bruxism index values ≥ 90th percentile were included in severe bruxism group (n = 111), and those with scores below 90th percentile were labelled as negligible bruxism group (n = 981). An individual's bruxism status was based on clinical oral examination and participants' report of bruxism. The sample included 1092 subjects, aged 20-60 years (mean age 37Â♰6 ± 7Â♸5). The aim of the study was to evaluate the relationship between bruxism, and sociodemographic parameters, symptoms of temporomandibular disorders (TMD), personality and war experience among Croatian navy employees. ![]() 1995 50(2):207–9.Risk factors for bruxism among Croatian navy employees. Obliterative bronchiolitis caused by multiple tumourlets and microcarcinoids successfully treated by single lung transplantation. Sheerin N, Harrison NK, Sheppard MN, Hansell DM, Yacoub M, Clark TJ. Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis. 2009 27(28):4656–63.įazio N, Buzzoni R, Delle Fave G, Tesselaar ME, Wolin E, van Cutsem E, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. Rinke A, Muller HH, Schade-Brittinger C, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case Series. The expanding role of somatostatin analogs in the management of neuroendocrine tumors. Management of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Review and a Single Center Experience. Myint ZW, McCormick J, Chauhan A, Behrens E, Anthony LB. Neuroendocrine and Adrenal Tumors NCCN Guidelines Version 2.2020. Diffuse Neuroendocrine Cell Hyperplasia: Report of Two Cases. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) with liver metastases. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study. Mengoli MC, Rossi G, Cavazza A, Franco R, Marino FZ, Migaldi M, et al. ![]() Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. 2012 118(3):612–9.ĭavies SJ, Gosney JR, Hansell DM, Wells AU, du Bois RM, Burke MM, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity. ![]() Gorshtein A, Gross DJ, Barak D, Strenov Y, Refaeli Y, Shimon I, et al. Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). Gosney JR, Williams IJ, Dodson AR, Foster CS. 2020 First large retrospective study demonstrating symptomatic improvement in chronic DIPNECH symptoms with somatostatin analog therapy.Īlmquist D, Cabrera A, Sonbol MB, et al. Somatostatin Analogs Improve Respiratory Symptoms in Patients With Diffuse Idiopathic Neuroendocrine Cell Hyperplasia. Al-Toubah T, Strosberg J, Halfdanarson T, et al.Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a systematic overview. Nassar AA, Jaroszewski DE, Helmers RA, Colby TV, Patel BM, Mookadam F. Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. Īguayo SM, Miller YE, Waldron JA Jr, Bogin RM, Sunday ME, Staton GW Jr, et al.Papers of particular interest, published recently, have been highlighted as:
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |